Cost-Effectiveness in Clinical Trials

2

Judith R. Lave, 

Judith R. Lave

University of Pittsburgh, Pittsburgh, PA, USA

Search for more papers by this author

Richard G. Frank, 

Richard G. Frank

University of Pittsburgh, Pittsburgh, PA, USA

Search for more papers by this author

Judith R. Lave, 

Judith R. Lave

University of Pittsburgh, Pittsburgh, PA, USA

Search for more papers by this author

Richard G. Frank, 

Richard G. Frank

University of Pittsburgh, Pittsburgh, PA, USA

Search for more papers by this author

First published: 15 July 2005

https://doi.org/10.1002/0470011815.b2a01014

No abstract is available for this article.

References

• 1 Bergner, M., Bobbitt, R. A., Carter, W. B. & Gilson, B. S. (1981). The sickness impact profile: development and final revision of a health status measure, Medical Care 19, 787–805.
  10.1097/00005650-198108000-00001

  CAS PubMed Web of Science® Google Scholar
• 2 Briggs, A. H. & Gray, A. M. (1998). Power and sample size calculations for stochastic cost-effectiveness analysis, Medical Decision Making 18, S81–S92.
  10.1177/0272989X98018002S10

  CAS PubMed Web of Science® Google Scholar
• 3 Brooks, R. with the EuroQol Group (1996). EuroQol: the current state of play, Health Policy 36, 53–72.
  10.1016/0168-8510(96)00822-6

  PubMed Google Scholar
• 4 Coyle, D., Davies, L. & Drummond, M. F. (1998). Emerging issues in designing economic evaluations alongside clinical trials, International Journal of Health Technology Assessment in Health Care 14, 135–144.
  10.1017/S0266462300010588

  CAS PubMed Web of Science® Google Scholar
• 5 Drummond, M. (1995). Economic analysis alongside clinical trials: problems and potential, Journal of Rheumatology 22, 1403–1407.
  CAS PubMed Web of Science® Google Scholar
• 6 Drummond, M. & Davies, L. (1992). Economic analysis alongside clinical trials: revisiting and methodological issues, International Journal of Health Technology Assessment in Health Care 7, 561–573.
  10.1017/S0266462300007121

  PubMed Google Scholar
• 7 Drummond, M., O'Brien, B. J., Stoddart, G. L. & Torrance, G. W. (1997). Methods for the Economic Evaluation of Health Care Programmes, 2nd Ed. Oxford University Press, New York.
  Google Scholar
• 8 EuroQol Group (1990). EuroQol: a new facility for the measurement of health-related quality of life, Health Policy 16, 199.
  10.1016/0168-8510(90)90421-9

  PubMed Web of Science® Google Scholar
• 9 Fitzpatrick, R. & Davies, L. (1998). Health economics and quality of life in cancer trials: report based on a UKCCCR workshop, British Journal of Cancer 77, 1543–1548.
  10.1038/bjc.1998.254

  CAS PubMed Web of Science® Google Scholar
• 10 Gold, M. R., Patrick, D. L., Torrance, G. W., Fryback, D. G., Hadorn, D. C., Kamlet, M. S., Daniels, N. & Weinstein, M. C. (1996). Identifying and valuing outcomes, in Cost-Effectiveness in Health and Medicine, M. R. Gold, J. E. Siegel, L. B. Russel & M. C. Weinstein, eds. Oxford University Press, New York, pp. 82–134.
  Google Scholar
• 11 M. R. Gold, J. E. Siegel, L. B. Russell & M. C. Weinstein, eds. (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press, New York.
  10.1093/oso/9780195108248.001.0001

  CAS PubMed Web of Science® Google Scholar
• 12 Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56–62.
  10.1136/jnnp.23.1.56

  CAS PubMed Web of Science® Google Scholar
• 13 Hargreaves, W. A., Shumway, M., Hu, T. W. & Currel, B. (1998). Cost Outcomes Methods for Mental Health. Academic Press, San Diego.
  Google Scholar
• 14 Hunt, S., McEwen, J. & McKenna, S. P. (1986). Measuring Health Status. Croom Helm, London.
  Google Scholar
• 15 Kaplan, R. M. (1999). Health-related quality of life in mental health services evaluation, in Cost-Effectiveness of Psychotherapy, N. E. Miller & K. M. Magruder, eds. Oxford University Press, New York, Chapter 16, pp. 160–173.
  Google Scholar
• 16 Kaplan, R. M. & Anderson, J. P. (1988). A general health policy model: update and applications, Health Services Research 23, 203–235.
  CAS PubMed Web of Science® Google Scholar
• 17 Kind, P. (1996). The EuroQol instrument: an index of health-related quality of life, in Quality of Life and Pharmacoeconomics in Clinical Trials, B. Spilker, ed. Lippincott-Raven, Philadelphia.
  Google Scholar
• 18 Laupacis, A., Fenny, D., Detsky, A. S. & Tugwell, P. X. (1992). How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluation, Canadian Medical Association Journal 146, 473–481.
  CAS PubMed Web of Science® Google Scholar
• 19 Lave, J. R. & Schulberg, H. C. (1999). Integrating cost-effectiveness analyses within clinical trials of treatment for major depression in primary-care practice, in Cost-Effectiveness of Psychotherapy, N. E. Miller & K. M. Magruder, eds. Oxford University Press, New York, pp. 75–84.
  Google Scholar
• 20 Lave, J. R., Frank, R. G., Schulberg, H. C. & Kamlet, M. S. (1998). Cost-effectiveness of treatments for major depression in primary care practice, Archives of General Psychiatry 55, 645–651.
  10.1001/archpsyc.55.7.645

  CAS PubMed Web of Science® Google Scholar
• 21 Manheim, L. M. (1998). Health services research clinical trials: issues in the evaluation of economic costs and benefits, Controlled Clinical Trials 19, 149–158.
  10.1016/S0197-2456(97)00146-3

  CAS PubMed Web of Science® Google Scholar
• 22 McDowell, I. & Newell, C. (1996). Measuring Health: A Guide to Rating Scales and Questionnaires, 2nd Ed. Oxford University Press, New York.
  Web of Science® Google Scholar
• 23 Melzack, R. (1975). The McGill Pain Questionnaire: major properties and scoring methods. Pain 1, 277–299.
  10.1016/0304-3959(75)90044-5

  CAS PubMed Web of Science® Google Scholar
• 24 Mullahy, J. & Manning, W. G. (1994). Statistical issues in cost effectiveness analyses, in Valuing Health Care: Costs, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies, F. Sloan, ed. Cambridge University Press, New York.
  Google Scholar
• 25 Ness, R. B., Soper, D. R., Peipert, J., Sondheimer, S. J., Holley, R. L., Sweet, R. L., Hemsell, D. L., Randall, H., Hendrix, S. L., Bass, D. C., Kelsey, S. F., Songer, T. J. & Lave, J. R. (1998). Design of the PID Evaluation and Clinical Health (PEACH) Study, Controlled Clinical Trials 19, 499–514.
  10.1016/S0197-2456(98)00022-1

  CAS PubMed Web of Science® Google Scholar
• 26 Patrick, D. L. & Erickson, P. (1993). Health Status and Health Policy: Allocating Resources to Health Care. Oxford University Press, New York.
  Google Scholar
• 27 Pauly, M. V. (1994). Valuing health care benefits in monetary terms, in Valuing Health Care: Cost, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies, F. Sloan, ed. Cambridge University Press, New York.
  Google Scholar
• 28 Schelling, T. C. (1984). The life you save may be your own, in Choice and Consequence, T. C. Schelling, ed. Harvard University Press, Cambridge.
  Google Scholar
• 29 Stewart, A. L. & Ware, J. E. (1992). Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Duke University Press, Durham.
  10.7249/CB361

  Google Scholar
• 30 Tolley, G., Kenkel, D. & Fabian, R. (1994). Valuing Health for Policy. University of Chicago Press, Chicago.
  Google Scholar
• 31 Torrance, G. W. (1986). Measurement of health utilities for economic appraisal, Journal of Health Economics 5, 1–30.
  10.1016/0167-6296(86)90020-2

  CAS PubMed Web of Science® Google Scholar
• 32 Torrance, G. W., Furlong, D., Fenny, D. & Boyle, M. (1995). Multi-attribute preference functions: health utilities index, Pharmacoeconomics 9, 503–520.
  10.2165/00019053-199507060-00005

  Web of Science® Google Scholar
• 33 Torrance, G. W., Thomas, W. H. & Sackett, D. L. (1972). A utility maximizing model for evaluation of health care programs, Health Services Research 7, 118–133.
  CAS PubMed Google Scholar
• 34 van Hout, B. A., Al, M. J., Gordon, G. S. & Ruten, F. F. (1994). Cost, effects and C.E-ratios alongside a clinical trial, Health Economics, 3, 309–319.
  10.1002/hec.4730030505

  PubMed Web of Science® Google Scholar
• 35 Ware, J. & Sherbourne, C. (1992). The MOS 36-item short form health survey I: conceptual framework and item selection, Medical Care 30, 473–483.
  10.1097/00005650-199206000-00002

  CAS PubMed Web of Science® Google Scholar
• 36 Weisbrod, B. A. (1981). Benefit-cost analysis of a controlled experiment: treating the mentally ill, Journal of Human Resources 16, 523–548.
  10.2307/145235

  CAS PubMed Web of Science® Google Scholar
• 37 Wells, K. B. (1999). Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research, American Journal of Psychiatry 156, 5–10.
  10.1176/ajp.156.1.5

  CAS PubMed Web of Science® Google Scholar

Encyclopedia of Biostatistics

Browse other articles of this reference work:

• BROWSE BY TOPIC
• BROWSE A-Z

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption